EUVIMEDObjevte EUVIMED
VergleichsstudieKohortenstudieOpen access · CC BY-NC 4.0

Thirty‐day risk of digoxin toxicity among older adults co‐prescribed trimethoprim‐sulfamethoxazole versus amoxicillin: A population‐based cohort study

Flory T Muanda iD, Matthew A Weir, Fatemeh Ahmadi, Eric McArthur, Jessica M Sontrop, Sheikh S Abdullah, Brad L Urquhart, Hasti Sadeghi, Richard B Kim, Amit X Garg

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2024

DOI: 10.1002/phar.2948 ↗

At a glance

Vergleichsstudie in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2024. Written by Flory T Muanda and 9 co-authors. Institution: ICES Western, London, Ontario, Canada. Major MEDLINE topics: Digoxin, Amoxicillin, Trimethoprim, Sulfamethoxazole Drug Combination, Anti-Bacterial Agents. 44 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Ontario Ministry of Health (MOH) and the Ministry of Long-Term Care (MLTC).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Importance Trimethoprim‐sulfamethoxazole (TMP‐SMX) may increase digoxin concentration, a medication with a narrow therapeutic index. Small changes in digoxin concentration could predispose individuals to the risk of toxicity.

Objective

To characterize the risk of digoxin toxicity in older adults taking digoxin following co‐prescription of TMP‐SMX compared with co‐prescription of amoxicillin. Design, Settings, and Participants Retrospective population‐based cohort study in Ontario, Canada (2002–2020) using linked health care data. Participants comprised 47,961 older adults taking digoxin (58% women; median age 80 years [interquartile range 74–86]) who were newly treated with TMP‐SMX ( n = 10,273) compared with those newly treated with amoxicillin ( n = 37,688). Exposure Co‐prescription of TMP‐SMX versus amoxicillin in older adults concurrently taking digoxin. Main Outcome and Measure The primary outcome was a hospital encounter (i.e., hospital admission or emergency department visit) with digoxin toxicity within 30 days of the antibiotic prescription. Inverse probability of treatment weighting on the propensity score was used to balance comparison groups on indicators of baseline health. Weighted risk ratios (RR) were obtained using modified Poisson regression and weighted risk differences (RD) using binomial regression. The number needed to harm (NNH) was calculated as 1/RD.

Results

A hospital encounter with digoxin toxicity occurred in 49/10,273 (0.48%) patients treated with TMP‐SMX versus 32/37,688 (0.08%) in those treated with amoxicillin (weighted RR, 5.71 [95% confidence interval (CI), 3.19 to 10.24]; weighted RD, 0.39% [95% CI, 0.25% to 0.53%]; NNH 256 [95% CI, 233 to 400]). Conclusion and Relevance In older adults taking digoxin, the 30‐day risk of a hospital encounter with digoxin toxicity was nearly 6 times higher in those co‐prescribed TMP‐SMX versus amoxicillin, although the absolute risk difference was low (0.4%). Physicians should prescribe an alternative antibiotic when clinically appropriate. If TMP‐SMX must be co‐prescribed with digoxin (if the benefit is believed to outweigh the risk), digoxin should be dose‐reduced on an individual basis.

Subjects

MeSH terms (MEDLINE)

DigoxinAmoxicillinTrimethoprim, Sulfamethoxazole Drug CombinationAnti-Bacterial AgentsHumansAgedFemaleMaleAged, 80 and overRetrospective StudiesCohort StudiesDrug InteractionsOntarioCardiotonic Agents

Author keywords

TMP‐SMXamoxicillindigoxindrug drug interactiontoxicity

Substances

DigoxinAmoxicillinTrimethoprim, Sulfamethoxazole Drug CombinationAnti-Bacterial AgentsCardiotonic Agents

Authors and institutions

  • ICES Western, London, Ontario, Canada.
  • Department of Physiology and Pharmacology, Western University, London, Ontario, Canada.
  • Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada.
  • Division of Nephrology, Department of Medicine, Western University, London, Ontario, Canada.
  • Lawson Health Research Institute, London Health Sciences Centre, London, Ontario, Canada.
  • Department of Biology, Western University, London, Ontario, Canada.

ORCID profiles: Flory T Muanda

Funding

  • Ontario Ministry of Health (MOH) and the Ministry of Long-Term Care (MLTC)

Cite

APA

Muanda, F. T., Weir, M. A., Ahmadi, F., McArthur, E., Sontrop, J. M., Abdullah, S. S., Urquhart, B. L., Sadeghi, H., Kim, R. B., & Garg, A. X. (2024). Thirty‐day risk of digoxin toxicity among older adults co‐prescribed trimethoprim‐sulfamethoxazole versus amoxicillin: A population‐based cohort study. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1002/phar.2948

Vancouver

Muanda FT, Weir MA, Ahmadi F, McArthur E, Sontrop JM, Abdullah SS, et al. Thirty‐day risk of digoxin toxicity among older adults co‐prescribed trimethoprim‐sulfamethoxazole versus amoxicillin: A population‐based cohort study. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2024. doi:10.1002/phar.2948

BibTeX
@article{Muanda2024,
  author = {Muanda, Flory T and Weir, Matthew A and Ahmadi, Fatemeh and McArthur, Eric and Sontrop, Jessica M and Abdullah, Sheikh S and Urquhart, Brad L and Sadeghi, Hasti and Kim, Richard B and Garg, Amit X},
  title = {Thirty‐day risk of digoxin toxicity among older adults co‐prescribed trimethoprim‐sulfamethoxazole versus amoxicillin: A population‐based cohort study},
  journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
  year = {2024},
  doi = {10.1002/phar.2948}
}
Start for free →